It is absurd that the stock would move this heavy on a completety meaningless remark.
Question, could some fund/institution/etc. think MNTA could profit (future or course) from a permanent impairment to the raw heparin supply (triggered by the NY times artical that was REALLY scary if you understand the Chinease supply chain)?
I don't see why this would be the case, but sometimes the financial guys don't follow details that well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.